 | Immunovant, Inc. | |||
| NMS : IMVT || Location: United States | ||||
$28.5+0.18 (+0.65%) |
0.06 M | 28.06 - 28.64 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 9.020 M |
| March 15, 2024 | 9.354 M |
| Feb. 29, 2024 | 8.682 M |
| Feb. 15, 2024 | 9.013 M |
| Jan. 31, 2024 | 8.309 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.44 | -0.36 | 18.16% |
| 09/30/2023 | -0.48 | -0.45 | 6.25% |
| 06/30/2023 | -0.46 | -0.57 | -25.19% |
| 03/31/2023 | -0.44 | -0.46 | -5.41% |
| 12/31/2022 | -0.40 | -0.49 | -23.64% |
IMVT Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 145.293M | Shares Float | 64.359M |
| Short Float | 9.020M | Market Cap | 4114.70M |
| Institution ownership | 47.60% | Insider ownership | 55.547% |
| Earnings Date | 05/20/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -1.81 | Forward EPS | -1.88 |